The country is also advancing the integration of TCM into modern healthcare by optimizing its clinical use and expanding ...

China's commitment to foster innovation and advance high-standard opening-up has provided global pharmaceutical companies ...

The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to discover and develop next-generation multi-specific antibodies for ...

Sino Biopharm has a good financial position. As of December 2024, it has CNY 9.6 billion in cash on hand and CNY 9.6 billion in debt. Total debt outstanding is 14.7% of its total assets. Its capital ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

LONDON (Reuters) - AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the ...

These attitudes are time and again reflected in Dutton’s commentaries and policies, particularly directed towards certain ...

America's pharmaceutical giants have been plotting to torpedo Australia's Pharmaceuticals Benefits Scheme, despite securing ...

According to the Dutch regulatory authority, the CMA could help reduce vulnerabilities in supply chains and improve the ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

You've probably heard a lot about something called the Pharmaceutical Benefits Scheme — or the PBS — this week. Here are some ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...